Last edition
News about Industrial talks
Proprietary outsourcing platform aims to get biotechs off the ground with fast and seamless CRO matching.
Industrial talks | 14/11/2023 | By Manvi | 638
Piramal Pharma Gets EIR from US FDA for Bethlehem Plant
The EIR report signifies the closure of the inspection.
Industrial talks | 10/11/2023 | By Manvi | 1091
Allcargo Supply Chain Launches State-Of-The Art Chemical Warehouse at Navi Mumbai
The warehousing facility is equipped with, cold storage options for maintaining temperatures below 25 degree Celsius.
Industrial talks | 10/11/2023 | By Manvi | 859
Great Place to Work Institute Certifies Thermo Fisher Scientific for Fifth Consecutive Year
The Company has been ranked among the 100 Best Companies for Women in India for the second year in a row by Avtar and Seramount.
Industrial talks | 04/11/2023 | By Manvi | 683
With this year’s theme, ‘Epicentre of Progress’, the event showcases solutions for the entire value chain, from research to end-of-line packaging.
Industrial talks | 29/08/2023 | By Manvi | 760
Glenmark Pharmaceuticals in Process of Recalling 1,200 Bottles of Subpotent Hypertension Drug in USA
The affected lot has been manufactured at the Goa plant of the Mumbai-based drug firm and then supplied to Glenmark Pharmaceuticals Inc, USA, the USFDA said.
Industrial talks | 29/08/2023 | By Manvi | 901
Nathalie Daste brings extensive experience in organization design, transformation and capability building in the healthcare sector.
Industrial talks | 29/08/2023 | By Manvi | 1005
PharmaTech Expo 2023 Successfully Concludes in Gandhinagar
Pharmaceutical production, processing technologies, pharmaceutical systems, and pharmaceutical services were displayed at the three-day event.
Industrial talks | 28/08/2023 | By Manvi | 893
Kashmir University Hosts Lecture on Pharmaceutical Marketing Career
The placement of qualified students happens to be one of the top priorities of the university.
Industrial talks | 28/08/2023 | By Manvi | 542
Ferring Pharma and Royalty Pharma Enter into USD 500 Million Royalty Agreement for Adstiladrin
Royalty Pharma is acquiring a 5.1 percent royalty on net sales of Adstiladrin in the USA.
Industrial talks | 25/08/2023 | By Manvi | 736
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy